1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Colorectal Cancer Diagnostics Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Colorectal Cancer Diagnostics Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Prevalence of Colorectal Cancer
- 5.1.2 Launches of New Products
5.2 Market Opportunities
- 5.2.1 Growing Awareness of Colorectal Cancer
5.3 Future Trends
- 5.3.1 Artificial Intelligence in Colonoscopy
5.4 Impact of Drivers and Restraints
6. North America Colorectal Cancer Diagnostics Market Regional Analysis
6.1 North America Colorectal Cancer Diagnostics Market Overview
6.2 North America Colorectal Cancer Diagnostics Market Revenue 2021-2028 (US$ Million)
6.3 North America Colorectal Cancer Diagnostics Market Forecast Analysis
7. North America Colorectal Cancer Diagnostics Market Analysis – by Modality
7.1 Imaging Tests
- 7.1.1 Overview
- 7.1.2 Imaging Tests: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Stool-Based Tests
- 7.2.1 Overview
- 7.2.2 Stool-Based Tests: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Colorectal Cancer Diagnostics Market Analysis – by End User
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Diagnostic Laboratories
- 8.2.1 Overview
- 8.2.2 Diagnostic Laboratories: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Cancer Research Institutes
- 8.3.1 Overview
- 8.3.2 Cancer Research Institutes: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Colorectal Cancer Diagnostics Market – North America Analysis
9.1 North America
- 9.1.1 North America Colorectal Cancer Diagnostics Market Breakdown, by Key
Country, 2024 and 2028 (%)
- 9.1.1.1 North America Colorectal Cancer Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 US:
North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.1.1 US: North America Colorectal Cancer Diagnostics Market Breakdown, by Modality
- 9.1.1.1.2 US: North America Colorectal Cancer Diagnostics Market Breakdown, by End User
- 9.1.1.2 Canada:
North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.2.1 Canada: North America Colorectal Cancer Diagnostics Market Breakdown, by Modality
- 9.1.1.2.2 Canada: North America Colorectal Cancer Diagnostics Market Breakdown, by End User
- 9.1.1.3 Mexico :
North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.3.1 Mexico : North America Colorectal Cancer Diagnostics Market Breakdown, by Modality
- 9.1.1.3.2 Mexico : North America Colorectal Cancer Diagnostics Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. North America Colorectal Cancer Diagnostics Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Bruker Corp
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Clinical Genomics Technologies Pty Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 EDP Biotech Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Eiken Chemical Co., Ltd.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Epigenomics AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Illumina Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Medtronic Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Quest Diagnostics Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Siemens Healthineers AG
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For North America Colorectal Cancer Diagnostics Market
